Related Experiment Video
Updated: Jun 25, 2026

Using the Overlay Assay to Qualitatively Measure Bacterial Production of and Sensitivity to Pneumococcal Bacteriocins
Published on: September 30, 2014
Genome sequences of 36 Streptococcus pneumoniae strains optimized for the multiplexed opsonophagocytosis killing
Emma Graffice1, Chloe Meewes1, Feroze A Ganaie2
11Department of Medicine, Division of Infectious Disease, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Abstract:
A multiplexed opsonophagocytosis assay (MOPA) was developed as a cost-effective, high-throughput biological assay to evaluate the efficacy of pneumococcal vaccines by in vitro measurement of opsonophagocytic activity of anti-capsular antibodies. Here, we report draft genomes of the 36 strains of Streptococcus pneumoniae developed for use in the reference pneumococcal MOPA.
Insights
Researchers developed a new assay to test pneumococcal vaccines. This study reports the genomes of 36 Streptococcus pneumoniae strains used in this novel multiplexed opsonophagocytosis assay (MOPA) for vaccine efficacy testing.
Area of Science:
- Microbiology
- Immunology
- Vaccinology
Background:
- Pneumococcal vaccines are crucial for preventing invasive pneumococcal disease.
- Evaluating vaccine efficacy requires robust methods to measure immune responses.
- Opsonophagocytosis is a key mechanism of antibody-mediated protection against encapsulated bacteria like Streptococcus pneumoniae.
Purpose of the Study:
- To develop a cost-effective, high-throughput multiplexed opsonophagocytosis assay (MOPA) for evaluating pneumococcal vaccine efficacy.
- To report the draft genomes of 36 Streptococcus pneumoniae strains specifically selected for use in the reference pneumococcal MOPA.
Main Methods:
- Development of a multiplexed opsonophagocytosis assay (MOPA).
- Selection and preparation of 36 Streptococcus pneumoniae strains for MOPA.
- Whole-genome sequencing and draft genome assembly of the selected strains.
Main Results:
- Successful development of a multiplexed opsonophagocytosis assay (MOPA).
- Generation of draft genomes for 36 Streptococcus pneumoniae strains.
- These strains are suitable for use in the reference pneumococcal MOPA.
Conclusions:
- The developed MOPA provides a valuable tool for high-throughput, cost-effective evaluation of pneumococcal vaccine efficacy.
- The availability of these 36 Streptococcus pneumoniae genomes facilitates standardization and validation of the MOPA.
- This work supports the advancement of pneumococcal vaccine development and assessment.
Related Concept Videos
Special Staining Techniques
Modern Molecular Taxonomy

